Viemed Healthcare (VMD-T) Stock Predictions - Stockchase
WATCH LIST
6
Viemed Healthcare (VMD-T)

ON STOCKCHASE SINCE Jul 2018

0

Viemed Healthcare

VMD-T

16 watching          
Join the Discussion

Viemed Healthcare (VMD-T) SAVE Apr, 19, 2019, 3:54 am

7.43 0.08 (1.09%)

What the experts are saying about VMD-T



  • All
  • Filtered
Signal Opinion Expert
WEAK BUY
Viemed Healthcare(VMD-T) 

April 17, 2019

Small company. Market cap around $250 mill. Not very followed. Decent growth on the revenue side of around 40%. Still have to spend that money. The regulatory issues are big. Very competitive space. But they are very good at it.
0 0 0 0 0
0 comments
Small company. Market cap around $250 mill. Not very followed. Decent growth on the revenue side of around 40%. Still have to spend that money. The regulatory issues are big. Very competitive space. But they are very good at it.
0
0 0 0 0 0
0 comments
Kim Bolton

President , Black Swan Dexterita...

Price Price
$7.350
Owned Owned
No

STRONG BUY
Viemed Healthcare(VMD-T) 

April 4, 2019

He almost made it a Top Pick this time. It is a great company and he continues to love it. They were a former sleep management company and are now in the sleep apnea and oxygen space. He adds when the stock sells off. Over time it will continue to higher until it gets taken out.
0 0 0 0 0
0 comments
He almost made it a Top Pick this time. It is a great company and he continues to love it. They were a former sleep management company and are now in the sleep apnea and oxygen space. He adds when the stock sells off. Over time it will continue to higher until it gets taken out.
0
0 0 0 0 0
0 comments
Bruce Campbell

President , Stone Castle Investm...

Price Price
$7.010
Owned Owned
Yes

COMMENT
Viemed Healthcare(VMD-T) 

January 21, 2019

Took a beating from $8 to $4 upon news about a regulatory change that effected their medical products. He sold his shares. They rely on medicaid and Medicare, but he'd rather see them diversify their revenue base (which they're talking about doing). Good managers, though; he's met them. VMD was too volatile for him. If you own this and can stomach this volatility, VMD will eventually supply a good return.
0 0 0 0 0
0 comments
Took a beating from $8 to $4 upon news about a regulatory change that effected their medical products. He sold his shares. They rely on medicaid and Medicare, but he'd rather see them diversify their revenue base (which they're talking about doing). Good managers, though; he's met them. VMD was too volatile for him. If you own this and can stomach this volatility, VMD will eventually supply a good return.
0
0 0 0 0 0
0 comments
Jason Del Vicar

Portfolio , HollisWealth...

Price Price
$5.360
Owned Owned
No

BUY
Viemed Healthcare(VMD-T) 

October 4, 2018

They are an interesting company, spun out of the PHM-X group.  They have been executing very well.  There was a study that looked at what happens when people are closely monitored and it was very in favour in terms of what Biomed does.  This is home monitoring of the COPD disease so they can push them out of hospitals sooner.  They were growing at 20% per year organically.  He continues to own it.  PHM-X also looks really attractive now.

0 0 0 0 0
0 comments

They are an interesting company, spun out of the PHM-X group.  They have been executing very well.  There was a study that looked at what happens when people are closely monitored and it was very in favour in terms of what Biomed does.  This is home monitoring of the COPD disease so they can push them out of hospitals sooner.  They were growing at 20% per year organically.  He continues to own it.  PHM-X also looks really attractive now.

0
0 0 0 0 0
0 comments
Bruce Campbell

President , Stone Castle Investm...

Price Price
$7.110
Owned Owned
Yes

TOP PICK
Viemed Healthcare(VMD-T) 

September 24, 2018

They're the number three player in U.S. respiratory providers. They were spun out of Patient Home Monitoring. 30% ROE. As long as they execute and grow organically, their stock price will rise in 1-2 years. (no dividend, Anaylsts' price  target: $9.75)

0 0 0 0 0
0 comments

They're the number three player in U.S. respiratory providers. They were spun out of Patient Home Monitoring. 30% ROE. As long as they execute and grow organically, their stock price will rise in 1-2 years. (no dividend, Anaylsts' price  target: $9.75)

0
0 0 0 0 0
0 comments
Jason Del Vicar

Portfolio , HollisWealth...

Price Price
$6.450
Owned Owned
Yes

BUY
Viemed Healthcare(VMD-T) 

July 24, 2018

Provides breathing masks and other respiratory support services. He expects significant growth and sees it as reasonably priced relative to projected earnings.

0 0 0 0 0
0 comments

Provides breathing masks and other respiratory support services. He expects significant growth and sees it as reasonably priced relative to projected earnings.

0
0 0 0 0 0
0 comments
Robert McWhirte

President, Selective Asset Mana...

Price Price
$4.530
Owned Owned
No

Showing 1 to 6 of 6 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days